← Leaderboards
Juan Martin Arriaga
Icahn School Of Medicine At Mount Sinai
$577,368
Attributed
$577,368
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $192.5K · FY2022–24$200K$150K$100K$50K$0
'22
'23
'24
Funding mix
By agency
NIH$577,368 · 1
By mechanism
K22$577,368 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Chung Yin Kong$10,200,842
- Juan P Wisnivesky$34,328,417
- Keith Magnus Sigel$6,937,762
- Se-Min Kim$2,209,838
- Mone Zaidi$25,912,145
Others in their field
Other Rising Stars on “Epigenomics”
- Alanna Maguire · Mayo Clinic Rochester$9,942,431
- Daofeng Li · Salk Institute For Biological Studies$9,887,266
- Paola A Ramos · Mayo Clinic Rochester$7,298,203
- Travis Henry · Mayo Clinic Rochester$6,835,150
- Christopher Hartl · Epigenome Technologies, Inc.$4,417,564
- Logan Grosenick · Weill Medical Coll Of Cornell Univ$3,339,048
Research focus
EpigenomicsEvaluationAwardAndrogen Deprivation TherapyBoneAdvisory CommitteesCancer EtiologyCareerCareer DevelopmentBiological ModelsCessation Of LifeClinical TrialsBromodomainCrispr/Cas TechnologyCrispr ScreenDependenceDevelopment PlansDisease OutcomeDisseminated Malignant NeoplasmDrug DevelopmentEffective TherapyElectroporationEpigenetic ProcessExpenditure
Grant awards (3)
Identification of therapeutic vulnerabilities in prostate cancer bone metastasis$192,456
K22 · FY2024 · CA · contact PI
Identification of therapeutic vulnerabilities in prostate cancer bone metastasis$192,456
K22 · FY2023 · CA · contact PI
Identification of therapeutic vulnerabilities in prostate cancer bone metastasis$192,456
K22 · FY2022 · CA · contact PI